Evidence map›Paper›PMID 31711984›Full record

ArticleFree radical biology & medicine2020

Inhibition of CaMKII in mitochondria preserves endothelial barrier function after irradiation.

Stephen J Roy, Olha M Koval, Sara C Sebag, Karima Ait-Aissa, Bryan G Allen, Douglas R Spitz, Isabella M Grumbach

RetractedErratum issuedOpen access · hybridAbstract readRetracted Publication
In one paragraph

Article in Free radical biology & medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Mitochondrial CaArteriosclerosis, thrombosis, and vascular biology · 2022
    Article
  3. Article
  4. Article
  5. CaMKII oxidation regulates cockroach allergen-induced mitophagy in asthma.The Journal of allergy and clinical immunology · 2021
    Article
  6. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Stephen J RoyAbboud Cardiovascular Research Center, Division of Cardiovascular Medicine, Department of Internal Medicine, 169 Newton Rd, 4336 PBDB, University of Iowa, Iowa City, IA, 52242, USA.
Olha M KovalAbboud Cardiovascular Research Center, Division of Cardiovascular Medicine, Department of Internal Medicine, 169 Newton Rd, 4336 PBDB, University of Iowa, Iowa City, IA, 52242, USA.
Sara C SebagAbboud Cardiovascular Research Center, Division of Cardiovascular Medicine, Department of Internal Medicine, 169 Newton Rd, 4336 PBDB, University of Iowa, Iowa City, IA, 52242, USA.
Karima Ait-AissaAbboud Cardiovascular Research Center, Division of Cardiovascular Medicine, Department of Internal Medicine, 169 Newton Rd, 4336 PBDB, University of Iowa, Iowa City, IA, 52242, USA.
Bryan G AllenFree Radical and Radiation Biology Program, Department of Radiation Oncology, Holden Comprehensive Cancer Center, B180 Medical Laboratories, University of Iowa, Iowa City, IA, 52242, USA.
Douglas R SpitzFree Radical and Radiation Biology Program, Department of Radiation Oncology, Holden Comprehensive Cancer Center, B180 Medical Laboratories, University of Iowa, Iowa City, IA, 52242, USA.
Isabella M GrumbachAbboud Cardiovascular Research Center, Division of Cardiovascular Medicine, Department of Internal Medicine, 169 Newton Rd, 4336 PBDB, University of Iowa, Iowa City, IA, 52242, USA; Free Radical and Radiation Biology Program, Department of Radiation Oncology, Holden Comprehensive Cancer Center, B180 Medical Laboratories, University of Iowa, Iowa City, IA, 52242, USA; Veterans Affairs Health Care System, 601 Hwy 6 West Iowa City, IA, 52246, USA. Electronic address: isabella-grumbach@uiowa.edu.
University of Iowa · USIowa City VA Health Care System · US

Funding

Viral VectorP30CA086862 · NCI · UNIVERSITY OF IOWA · PI Christopher K Laubenthal · 2000 to 2026
$70.0M
Pulmonary Toxicology Facility CoreP30ES005605 · NIEHS · UNIVERSITY OF IOWA · PI Jong Sung Kim · 1990 to 2026
$40.5M
INTERDISCIPLINARY CARDIOVASCULAR RESEARCH FELLOWSHIPT32HL007121 · NHLBI · UNIVERSITY OF IOWA · PI LONDON, BARRY · 1985 to 2020
$15.1M
Project 4: New Approaches to Improving the Effectiveness of Radionuclide Targeted Treatments in Neuroendocrine TumorsP50CA174521 · NCI · UNIVERSITY OF IOWA · PI ODORISIO, THOMAS · 2015 to 2021
$13.2M
Project 3: MRI Imaging of Redox Active Fe Predicts GBM Responses to Pharmacological AscorbateP01CA217797 · NCI · UNIVERSITY OF IOWA · PI CULLEN, JOSEPH J, SPITZ, DOUGLAS ROBERT · 2018 to 2022
$9.6M
Mitochondrial CaMKII drives smooth muscle migration and neointimal hyperplasiaR01HL108932 · NHLBI · UNIVERSITY OF IOWA · PI GRUMBACH, ISABELLA MARIA · 2012 to 2021
$3.6M
CaMKII as a regulator of diabetic retinopathyI21RX001561 · VA · IOWA CITY VA MEDICAL CENTER · PI GRUMBACH, ISABELLA MARIA · 2015 to 2017
–
Mitochondrial CAMKII in smooth muscle as key regulator of hypertension and vascular remodelingI01BX000163 · VA · OKLAHOMA CITY VA MEDICAL CENTER · PI Isabella Maria Grumbach · 2011 to 2026
–
BLRD VA I01 BX000163NCI NIH HHS P01 CA217797NCI NIH HHS P30 CA086862NCI NIH HHS P50 CA174521NHLBI NIH HHS R01 HL108932NHLBI NIH HHS T32 HL007121NIEHS NIH HHS P30 ES005605RRD VA I21 RX001561
6 · The paper itself

Abstract

Damage to the microvascular endothelium is an important part of normal tissue injury after radiation exposure and driven by the production of pro-oxidants. The Ca2+/calmodulin-dependent protein kinase II is present in the mitochondrial matrix (mitoCaMKII) where it regulates Ca2+ uptake via the mitochondrial Ca2+ uniporter (MCU) and pro-oxidant production. Here, we demonstrate that radiation exposure disrupts endothelial cell barrier integrity in vitro, but can be abrogated by inhibition of mitoCaMKII, MCU, or opening of the mitochondrial transition pore. Scavenging of mitochondrial pro-oxidants with mitoTEMPO before, but not after irradiation, protected barrier function. Furthermore, markers of apoptosis and mitochondrial pro-oxidant production were elevated at 24 h following irradiation and abolished by mitoCaMKII inhibition. Endothelial barrier dysfunction was detected as early as 2 h after irradiation. Despite only mildly impaired mitochondrial respiration, the intracellular ATP levels were significantly reduced 4 h after irradiation and correlated with barrier function. MitoCaMKII inhibition improved intracellular ATP concentrations by increasing glycolysis. Finally, DNA double strand break repair and non-homologous end joining, two major drivers of ATP consumption after irradiation, were greatly increased but not significantly affected by mitoCaMKII inhibition. These findings support the hypothesis that mitoCaMKII activity is linked to mitochondrial pro-oxidant production, reduced ATP production, and loss of endothelial barrier function following irradiation. The inhibition of mitoCaMKII is a promising approach to limiting radiation-induced endothelial injury.

Indexed as

Calcium-Calmodulin-Dependent Protein Kinase Type 2Calcium ChannelsCalciumEndotheliumMitochondriaCalciumCalcium-Calmodulin-Dependent Protein Kinase Type 2Calcium ChannelsCalmodulin-dependent kinase IIEndotheliopathyEndotheliumMitochondria/mitochondrial Ca(2+) uniporterRadiation

Identifiers

PMID31711984
PMCPMC7274136
OpenAlexW2985357732

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.